EN DE

UHT Fair Value & Analysis

Real Estate · US · Market cap $559M

U UHT logo UHT UHT · US
Price$42.72
Fair Value$21.57
Upside-49.5%
Quality60/100
Watch UHT for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Solidly profitable · 17.7% net margin
Low debt · generates free cash flow
7.34% dividend yield
Ranks above peers (10/15)
Wide moat 66/100
Evidence: High Range $16.18 – $26.97 Share as image

Fair value as of: Jul 27, 2026

From 16 valuation models · updated 14 days ago

Share price −2.2% over the past month.

A solid business, but screening 50% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case ($26.97). The favourable scenario is already priced in.
  • Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder.
  • As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$53.73 $28.03 Fair Value $21.57 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 27, 2026.

How to read this chart

60‑month range $28.03 – $53.73 · fair‑value band $16.18 – $26.97 · the $42.72 price screens above the $21.57 fair value. Dashed = 300-day average. As of Jul 27, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

UHT (UHT) currently trades at $42.72, while our model-based Fair Value estimate is $21.57, implying the stock looks roughly 49.5% overvalued today. The Quality Score stands at 60/100 (solid quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, UHT generated revenue of $101M at a net margin of 17.7%. Revenue grew 0.3% year over year. It earns a return on equity of 11.2%. Net debt stands at $379M. Fundamentals as of Jul 27, 2026

Our scenario range runs from $16.18 (bear case) to $26.97 (bull case); at $42.72, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 3% below its 52-week high and 26% above its 52-week low, currently above its 200-day average. For context, the median of 10 Real Estate peers we cover trades at -53% fair-value upside, at -50%, UHT screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF $31.98 $43.68 $58.01 80
Residual Income $9.56 $10.61 $13.92 76
Rev-Margin DCF $25.11 $37.53 $51.23 74
All 16 models by family
DCF Models
FCF DCF $31.64 $44.90 $62.08 38
5Y Revenue Exit $25.11 $37.13 $51.94 39
5Y EBITDA Exit $42.81 $69.58 $100.27 41
10Y Revenue Exit $26.93 $37.77 $51.39 36
10Y EBITDA Exit $37.74 $58.14 $84.47 37
Dividend Discount
Gordon GGM $22.97 $41.40 $56.99 70
DDM Multi-Stage $22.97 $34.32 $44.22 61
Multiples
P/S Multiple $16.18 $21.57 $26.97 58
P/B Multiple $16.18 $21.57 $26.97 55
EV/EBIT $40.49 $54.27 $68.05 53
EV/EBITDA $57.46 $76.89 $96.33 54
EV/Revenue $21.95 $31.72 $41.49 43
Asset-Based
NCAV (Graham) $5.49 $7.36 $10.98 50
Growth DCF
Growth DCF $31.98 $43.68 $58.01 80
Rev-Margin DCF $25.11 $37.53 $51.23 74
Economic Profit
Residual Income $9.56 $10.61 $13.92 76

Widest divergence: DCF Models ($44.90) versus Asset-Based ($7.36). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) $101M
Revenue growth (YoY) +0.3%
Net margin 17.7%
Return on equity 11.2%
Free cash flow $49.1M FY2025
P/E ratio 31.5
More key figures
Operating margin 37.8%
EPS (TTM) $1.28
Dividend yield 7.3%
EPS growth (YoY) +5.9%
Net debt $379M FY2025

Figures from reported company fundamentals · as of Jul 27, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 60/100

Of which business quality 55 · Market factors (momentum, volatility) 65

Profitability 38
Margins and returns on capital today
Quality Growth 37
Are margins and returns improving?
Cashflow 95
Earnings quality: real cash, not paper profit
Fin. Strength 11
Balance sheet, leverage, solvency risk
Investment 87
Disciplined investing over empire-building
Low Volatility 77
Calm price path (market factor)
Momentum 55
Price trend over the last 3–12 months (market factor)
52W Momentum 70
Distance to the 52-week high (market factor)
Net Issuance 80
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service-related facilities including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute care facilities, surgery centers, childcare centers, and medical office buildings.

Full company description

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service-related facilities including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute care facilities, surgery centers, childcare centers, and medical office buildings. The Trust has seventy-seven investments in twenty-one states. It is based in King of Prussia, Pennsylvania. Universal Health Realty Income Trust was incorporated in 1986 in Maryland.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

UHT reported revenue of $99.2M in FY2025 versus $84.2M in FY2021, a compound +4.2%/yr. Reported net income was $17.6M in FY2025, compounding −36.6%/yr from FY2021.

Growth Quality 74/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
$99.2M
Latest YoY
+0.2%
Avg. growth/yr (3Y)
+3.1%
Avg. growth/yr (5Y)
+4.9%
Avg. growth/yr (39Y)
+5.2%
Revenue +4.2%/yr
FY21 $84.2M
FY22 $90.6M
FY23 $95.6M
FY24 $99.0M
FY25 $99.2M
Net income −36.6%/yr
FY21 $109M
FY22 $21.1M
FY23 $15.4M
FY24 $19.2M
FY25 $17.6M

UHT screens 50% overvalued. Compare with Welltower Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "UHT Fair Value". https://www.fairvalue-calculator.com/stock/UHT

Peer Group

REIT - Healthcare Facilities · 28 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 60 · Above median
Fair Value upside −50% · Below median
Return on equity (TTM) 11% · Top 25%
Return on assets 4% · Top 25%
Net margin (TTM) 18% · Above median
Operating margin (TTM) 38% · Below median
Revenue growth 0% · Below median
Dividend yield (TTM) 7.3% · Top 25%
Debt / equity 0.12× · Lower than 75% of peers

Valuation Multiples vs REIT - Healthcare Facilities median · lower = cheaper

P/E (TTM) 31.5× · Pricier than median
P/B 3.67× · Pricier than 75% of peers
P/S (TTM) 5.53× · Cheaper than median
P/FCF 11.4× · Cheaper than 75% of peers
EV/EBITDA 8.6× · Cheaper than 75% of peers
PEG 0.63× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 2 · sector 30
PAST 45 · sector 21
HEALTH 94 · sector 71
DIVIDEND 100 · sector 100

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more REIT - Healthcare Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 27, 2026).

Stock Price Fair Value vs Fair Value
Welltower Inc WELL $231.59 $42.21 -82%
Ventas, Inc VTR $100.53 $18.07 -82%
Omega Healthcare Investors, Inc OHI $51.72 $33.69 -35%
Healthpeak Properties, Inc DOC $22.27 $7.02 -68%
American Healthcare REIT, Inc AHR $56.38 $11.04 -80%
CareTrust REIT, Inc CTRE $43.25 $23.07 -47%
Healthcare Realty Trust Incorporated HR $21.40 $20.60 -4%
Aedifica NV AED €69.85 €36.17 -48%
Chartwell Retirement Residences CSHUN C$22.81 C$3.52 -85%
Sabra Health Care REIT, Inc SBRA $22.36 $10.49 -53%

Compare UHT with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Real Estate stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is UHT overvalued or undervalued?
As of Jul 27, 2026, our model estimates a fair value of $21.57 versus a price of $42.72, about −50% (overvalued).
What is the fair value of UHT?
Our model-based fair value for UHT is $21.57 (as of Jul 27, 2026), built from audited fundamentals. The current price is $42.72.
What is the quality score of UHT?
UHT has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of UHT?
UHT reported trailing-twelve-month revenue of about $101M (latest available figure, as of Jul 27, 2026).
What is the net profit margin of UHT?
The net profit margin of UHT is about 17.7%, meaning it keeps roughly 17.7% of revenue as net income. Based on the latest reported figures.
Does UHT pay a dividend?
UHT currently shows a dividend yield of about 7.34% relative to its recent price (as of Jul 27, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track UHT and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.